BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 16113604)

  • 1. Th1-polarizing capacity of clinical-grade dendritic cells is triggered by Ribomunyl but is compromised by PGE2: the importance of maturation cocktails.
    Jongmans W; Tiemessen DM; van Vlodrop IJ; Mulders PF; Oosterwijk E
    J Immunother; 2005; 28(5):480-7. PubMed ID: 16113604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells matured by a prostaglandin E2-containing cocktail can produce high levels of IL-12p70 and are more mature and Th1-biased than dendritic cells treated with TNF-α or LPS.
    Landi A; Babiuk LA; van Drunen Littel-van den Hurk S
    Immunobiology; 2011 Jun; 216(6):649-62. PubMed ID: 21183242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncarinic acid C plus IFN-γ generates monocyte-derived dendritic cells and induces a potent Th1 polarization with capacity to migrate.
    Bae WK; Umeyama A; Chung IJ; Lee JJ; Takei M
    Cell Immunol; 2010; 266(1):104-10. PubMed ID: 20933226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bromelain treatment leads to maturation of monocyte-derived dendritic cells but cannot replace PGE2 in a cocktail of IL-1β, IL-6, TNF-α and PGE2.
    Karlsen M; Hovden AO; Vogelsang P; Tysnes BB; Appel S
    Scand J Immunol; 2011 Aug; 74(2):135-43. PubMed ID: 21449940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical grade maturation cocktail monophosphoryl lipid A plus IFNgamma generates monocyte-derived dendritic cells with the capacity to migrate and induce Th1 polarization.
    Ten Brinke A; Karsten ML; Dieker MC; Zwaginga JJ; van Ham SM
    Vaccine; 2007 Oct; 25(41):7145-52. PubMed ID: 17719152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
    Feili-Hariri M; Falkner DH; Morel PA
    J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quick generation of fully mature dendritic cells from monocytes with OK432, low-dose prostanoid, and interferon-alpha as potent immune enhancers.
    Sakakibara M; Kanto T; Inoue M; Kaimori A; Yakushijin T; Miyatake H; Itose I; Miyazaki M; Kuzushita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Immunother; 2006; 29(1):67-77. PubMed ID: 16365602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular ATP induces a distorted maturation of dendritic cells and inhibits their capacity to initiate Th1 responses.
    la Sala A; Ferrari D; Corinti S; Cavani A; Di Virgilio F; Girolomoni G
    J Immunol; 2001 Feb; 166(3):1611-7. PubMed ID: 11160202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of CpG ODN and Poly (I:C) to a standard maturation cocktail generates monocyte-derived dendritic cells and induces a potent Th1 polarization with migratory capacity.
    Zhu M; Xu W; Su H; Huang Q; Wang B
    Hum Vaccin Immunother; 2015; 11(7):1596-605. PubMed ID: 26039883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities.
    Mohty M; Vialle-Castellano A; Nunes JA; Isnardon D; Olive D; Gaugler B
    J Immunol; 2003 Oct; 171(7):3385-93. PubMed ID: 14500632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engagement of human monocyte-derived dendritic cells into interleukin (IL)-12 producers by IL-1beta + interferon (IFN)-gamma.
    Nakahara T; Urabe K; Fukagawa S; Uchi H; Inaba K; Furue M; Moroi Y
    Clin Exp Immunol; 2005 Mar; 139(3):476-82. PubMed ID: 15730393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected impairment of TNF-α-induced maturation of human dendritic cells in vitro by IL-4.
    Chabot V; Martin L; Meley D; Sensebé L; Baron C; Lebranchu Y; Dehaut F; Velge-Roussel F
    J Transl Med; 2016 Apr; 14():93. PubMed ID: 27080531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-y enhances T(H)1 polarisation of monocyte-derived dendritic cells matured with clinical-grade cytokines using serum-free conditions.
    Hildenbrand B; Lorenzen D; Sauer B; Hertkorn C; Freudenberg MA; Peters JH; Nesselhut T; Unger C; Azemar M
    Anticancer Res; 2008; 28(3A):1467-76. PubMed ID: 18630500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor-α promotes survival and phenotypic maturation of poly(I:C)-treated dendritic cells but impairs their Th1 and Th17 polarizing capability.
    Thorne A; Tomić S; Pavlović B; Mihajlović D; Džopalić T; Čolić M
    Cytotherapy; 2015 May; 17(5):633-46. PubMed ID: 25559144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties.
    Anguille S; Smits EL; Cools N; Goossens H; Berneman ZN; Van Tendeloo VF
    J Transl Med; 2009 Dec; 7():109. PubMed ID: 20021667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cigarette smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming.
    Vassallo R; Tamada K; Lau JS; Kroening PR; Chen L
    J Immunol; 2005 Aug; 175(4):2684-91. PubMed ID: 16081845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of mature dendritic cells fully capable of T helper type 1 polarization using OK-432 combined with prostaglandin E(2).
    Sato M; Takayama T; Tanaka H; Konishi J; Suzuki T; Kaiga T; Tahara H
    Cancer Sci; 2003 Dec; 94(12):1091-8. PubMed ID: 14662025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of alpha-Type-1 polarizing and standard dendritic cell cytokine cocktail for maturation of therapeutic monocyte-derived dendritic cell preparations from cancer patients.
    Trepiakas R; Pedersen AE; Met O; Hansen MH; Berntsen A; Svane IM
    Vaccine; 2008 Jun; 26(23):2824-32. PubMed ID: 18450338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy.
    Lee AW; Truong T; Bickham K; Fonteneau JF; Larsson M; Da Silva I; Somersan S; Thomas EK; Bhardwaj N
    Vaccine; 2002 Dec; 20 Suppl 4():A8-A22. PubMed ID: 12477423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined TLR-3/TLR-8 Signaling in the Presence of α-Type-1 Cytokines Represents a Novel and Potent Dendritic Cell Type-1, Anti-Cancer Maturation Protocol.
    Fevžer T; Poženel P; Zajc K; Tešić N; Švajger U
    Cells; 2022 Feb; 11(5):. PubMed ID: 35269457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.